Súkl (US-FDA) Certified 2019
We're pleased to announce that in January 2019 a regular inspection of Good Manufacturing Practice was conducted by the State Institute for Drug Control in Prague. On the basis of their findings a GMP Certificate will be issued to the full extent of our authorization to manufacture medicinal products. The inspection report will also be provided to the US FDA under the MRA agreement (mutual recognition of GMP inspection results) between the US and EU. Quinta-Analytica is one of the first companies whose inspection report has been requested by the US FDA from the State Institute for Drug Control, and we're honored to receive this recognition."
March 11, 2019